UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): June 5, 2019

 

 

VIVUS, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

Delaware

 

001-33389

 

94-3136179

(State or Other Jurisdiction
of Incorporation)

 

(Commission
File Number)

 

(I.R.S. Employer
Identification No.)

 

900 E. Hamilton Avenue, Suite 550

Campbell, CA 95008

(Address of Principal Executive Offices, and Zip Code)

 

(650) 934-5200

Registrant’s Telephone Number, Including Area Code

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock

 

VVUS

 

The Nasdaq Global Select Market

Preferred Share Purchase Rights

 

 

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

o       Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o       Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o       Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

 

 

Item 5.07.  Submission of Matters to a Vote of Security Holders.

 

On June 5, 2019, VIVUS, Inc. (the “Company”) held its 2019 Annual Meeting of Stockholders (the “Annual Meeting”).  At the Annual Meeting, the Company’s stockholders elected nine directors to serve until the next annual meeting of stockholders or until their successors are duly elected and qualified; approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers; ratified the Company’s appointment of OUM & Co. LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019; approved an amendment to the 2018 Equity Incentive Plan to increase the number of shares of Common Stock reserved for issuance thereunder by 600,000 shares; and approved an amendment to the 1994 Employee Stock Purchase Plan to increase the number of shares of Common Stock reserved for issuance thereunder by 400,000 shares.

 

The Company’s independent inspector of elections reported the voting results as follows:

 

(i)  Election of nine directors to serve until the next annual meeting of stockholders or until their successors are duly elected and qualified:

 

Name

 

For

 

Withheld

 

Broker Non-Votes

 

John P. Amos

 

2,457,453

 

216,718

 

6,416,480

 

Karen Ferrell

 

2,462,612

 

211,559

 

6,416,480

 

Edward A. Kangas

 

2,421,204

 

252,967

 

6,416,480

 

Thomas B. King

 

2,460,257

 

213,914

 

6,416,480

 

David Y. Norton

 

1,670,238

 

1,003,933

 

6,416,480

 

Jorge Plutzky, M.D.

 

2,464,977

 

209,194

 

6,416,480

 

Eric W. Roberts

 

2,417,668

 

256,503

 

6,416,480

 

Herman Rosenman

 

1,702,678

 

971,493

 

6,416,480

 

Allan L. Shaw

 

2,404,907

 

269,264

 

6,416,480

 

 

(ii)  Approval, on a non-binding advisory basis, of the compensation of the Company’s named executive officers:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

1,525,747

 

1,119,530

 

28,894

 

6,416,480

 

(iii)  Ratification of the appointment of OUM & Co. LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

8,713,851

 

294,252

 

82,548

 

0

 

(iv)  Approval of an amendment to the 2018 Equity Incentive Plan to increase the number of shares of Common Stock reserved for issuance thereunder by 600,000 shares:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

1,872,818

 

756,143

 

45,210

 

6,416,480

 

(v)  Approval of an amendment to the 1994 Employee Stock Purchase Plan to increase the number of shares of Common Stock reserved for issuance thereunder by 400,000 shares:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

2,302,808

 

330,755

 

40,608

 

6,416,480

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

VIVUS, INC.

 

 

 

/s/ John L. Slebir

 

John L. Slebir

 

Senior Vice President, Business Development and General Counsel

Date: June 7, 2019

 

 

3